Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-03 @ 8:12 AM
Study NCT ID:
NCT00283556
Status:
COMPLETED
Last Update Posted:
2010-01-20
First Post:
2006-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma
Sponsor:
Kentuckiana Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1068114
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None